Image: The Man Van. Credit: The Man Van and The Royal Marsden NHS Foundation Trust. Mobile testing ‘Man Van’ can diagnose ...

The Institute of Cancer Research has outlined its position on a number of policy issues in scientific and medical research. Our statements can be read and downloaded below. You may also be interested ...

Researchers have identified a key weakness in acute myeloid leukaemia, offering a promising new strategy to delay the ...

Dr Jessica May Hislop joined The Institute of Cancer Research as a Bioinformatician in the Houlston Lab in the Genetics and Epidemiology division. Together with her colleagues, she is working towards ...

Scientists have created a prototype test that can predict which drug combinations are likely to work for cancer patients in as little as 24 to 48 hours. Their cutting-edge technique uses artificial ...

Applications are now open for our 2024/2025 PhD studentships. Below you will find a link to further information about our application process, our application portal and mailing list, should you wish ...

Image: Human colon cancer cells with the cell nuclei stained red and the protein E-cadherin stained green. A pioneering study, has provided the most comprehensive analysis to date of the genetic ...

An international leader in the study of protein degradation – considered one of the most promising areas of drug discovery – has joined The Institute of Cancer Research, London. Dr Zoran Rankovic has ...

A special type of MRI scan where patients inhale 100% oxygen could result in lower radiotherapy doses for some cancer patients. The study led by scientists at The Institute of Cancer Research, London ...

Ribociclib – a drug already used to treat breast cancer – may help slow the growth of diffuse hemispheric glioma (DHG), new research has found. Diffuse hemispheric glioma is a rare, high-grade ...

Image: The Breast Cancer Now Generations Study team at The Institute of Cancer Research, London. Scientists are developing breast cancer risk tools that will help to identify women at high risk, even ...

A new test could predict the risk of a woman’s breast cancer spreading within 10 years of diagnosis more accurately than the current NICE-approved test, Oncotype DX, scientists have found. The new ...